Pervasive Developmental Disorder
25
1
2
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.0%
2 terminated out of 25 trials
88.9%
+2.4% vs benchmark
16%
4 trials in Phase 3/4
44%
7 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (25)
Behavior Therapy for Irritability in Autism
The Impact of a Virtual Magic Trick Training Program
Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
Genetic Contributions to Autism Spectrum Disorders
Facilitating Employment for Youth With Autism
Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
QoL and Stress in Parents of Children With Developmental Disabilities and Chronic Disease
GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs
Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
Shared Decision Making to Improve Care and Outcomes for Children With Autism
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.